Location History:
- Nuedrossenfeld, DE (2011)
- Neudrossenfeld, DE (2007 - 2014)
- Kulmbach, DE (2010 - 2018)
Company Filing History:
24 out of 444 
3 out of 3 
1 out of 8 Years Active: 2007-2018
Title: Stefan Limmer: Innovator in RNA Interference
Introduction
Stefan Limmer, based in Kulmbach, Germany, is a prominent inventor with an impressive portfolio of 28 patents. His innovative contributions, particularly in the field of gene expression inhibition, have garnered attention in the biomedical sector.
Latest Patents
Among his latest patents, Stefan has developed a groundbreaking method and medicament for inhibiting the expression of a given gene. This invention pertains to an isolated RNA that mediates RNA interference of a corresponding mRNA. It outlines a unique method of mediating RNA interference of a gene's mRNA in a cell or organism by utilizing the isolated RNA. This advancement has significant implications for therapeutic approaches to various genetic conditions.
Career Highlights
Stefan has made substantial strides in his career by working with leading pharmaceutical companies, notably Alnylam Pharmaceuticals, Inc. and Alnylam Europe AG. His role in these organizations has allowed him to focus on innovating solutions that address critical health challenges through genetic research.
Collaborations
Throughout his career, Stefan has collaborated with notable professionals, including his coworkers Roland Kreutzer and Hans-Peter Vornlocher. These partnerships have fostered an environment of innovation and have played a crucial role in the development of his significant inventions.
Conclusion
With a strong foundation in gene expression research and a rich history of innovation, Stefan Limmer continues to make impactful contributions to the field of biomedical science. His work on RNA interference stands as a testament to his dedication to enhancing our understanding of genetic mechanisms and developing novel therapeutic strategies.